SLS — Sellas Life Sciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Annual balance sheet for Sellas Life Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	21.4	17.1	2.53	13.9	71.8
Net Total Accounts Receivable
Net Total Receivables	0	—	—	—	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	23	17.8	3.17	16.3	75.2
Net Property, Plant And Equipment	0.723	0.874	0.858	0.925	0.963
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	26.3	20.9	6.22	19.4	78.3
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	4.98	15.5	13.7	9.51	7.02
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	5.93	16.1	14.2	9.97	7.47
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	20.3	4.85	-7.98	9.46	70.9
Total Liabilities & Shareholders' Equity	26.3	20.9	6.22	19.4	78.3
Total Common Shares Outstanding